TB Alliance, a not-for-profit organization with the mission of developing new, improved, and affordable TB treatments, announces the election of
The Global Alliance for TB Drug Development (TB Alliance) is pleased to announce the appointment of Dr. Carlos Morel to
PARIS AND NEW YORK, September 20, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and the Global Alliance for TB
WASHINGTON, DC/LONDON (July 23, 2012) – A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared
New Delhi, India – In advance of World TB Day and on the heels of news of outbreaks of deadly
Goal is to find new treatment that takes months, not years, and cures multiple forms of tuberculosis Announcement made at
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to the TB Alliance as a member
The TB Alliance and its partners have completed patient enrollment in REMox TB, a global Phase III clinical trial, which
(Durban, SOUTH AFRICA,) The TB Alliance today announced the launch of a collaboration with the National Institute of Allergy and
· AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign partnership to share information on TB drugs
